Saturday, October 31, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· April 4, 2026

Pepeto Announces Binance Listing Progress While Markets Wait For XRP Price To Reach The $10 Mark - Crypto News

View original at globenewswire.com
Pepeto Announces Binance Listing Progress While Markets Wait For XRP Price To Reach The $10 Mark - Crypto News Dubai, UAE, April 04, 2026 (GLOBE NEWSWIRE) -- Pepeto just confirmed that Binance listing preparations are in the final stretch…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Early PEPE trader spent $2,184 and realized $10.3 million in profit, a 4,718x return verified on chain

    60% confidence
  • XRP roadmap targets $2.80 for 2026 and $28 by 2030

    60% confidence
  • A Bonk holder turned $26,667 into $1 million in just seven days

    60% confidence
  • Binance listing preparations are in the final stretch

    60% confidence
  • XRP reaching $10 requires a $609 billion market cap and most analysts place that target in the 2029 to 2030 window

    60% confidence
  • XRP consensus price prediction sits between $3 and $5, roughly 3x from $1.32

    60% confidence
  • XRP price target of $8

    60% confidence
  • XRP ETFs recorded their first April inflow of $64,610 on April 3 after $31 million in March outflows

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com